Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check6 days agoChange DetectedThe page now shows TETON-1, a Phase 3 trial, with 99 locations (no specific sites listed) and revision v3.0.1 (Sept 2025, estimated) versus the old v3.0.0 (July 2025) with 101 locations and named sites.SummaryDifference1%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check42 days agoChange DetectedThe webpage has updated its version from v2.16.8 to v2.16.11 and has made changes to the dates and locations mentioned, specifically correcting the formatting of St. Louis and Winston Salem.SummaryDifference2%
- Check49 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.8, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
- Check56 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check63 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.7%
Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.